Journal Home > Volume 11 , Issue 3

Polyphenols, including phenolic acids, flavonoids, and procyanidins, are abundant in food and beverage derived from plants. Tea (Camellia sinensis) is particularly rich in polyphenols (e.g., catechins, theaflavins, thearubigins, gallic acid, and flavonols), which are thought to contribute to the health benefits of tea. High intake of tea polyphenols has been described to prevent and/or attenuate a variety of chronic pathological conditions like cardiovascular diseases, neurodegenerative diseases, diabetes, and cancer. This review focuses on established antioxidant and anti-inflammatory properties of tea polyphenols and underlying mechanisms of their involvement in inflammatory bowel diseases (IBD). Tea polyphenols act as efficient antioxidants by inducing an endogenous antioxidant defense system and maintaining intracellular redox homeostasis. Tea polyphenols also regulate signaling pathways such as nuclear factor-κB, activator protein 1, signal transducer and activator of transcriptions, and nuclear factor E2-related factor 2, which are associated with IBD development. Accumulating pieces of evidence have indicated that tea polyphenols enhance epithelial barrier function and improve gut microbial dysbiosis, contributing to the management of inflammatory colitis. Therefore, this study suggests that supplementation of tea polyphenols could prevent inflammatory conditions and improve the outcome of patients with IBD.


menu
Abstract
Full text
Outline
About this article

Antioxidant and anti-inflammatory roles of tea polyphenols in inflammatory bowel diseases

Show Author's information Van-Long TruongWoo-Sik Jeong( )
Food and Bio-industry Research Institute, School of Food Science & Biotechnology, College of Agriculture and Life Sciences, Kyungpook National University, Daegu 41566, Korea

Abstract

Polyphenols, including phenolic acids, flavonoids, and procyanidins, are abundant in food and beverage derived from plants. Tea (Camellia sinensis) is particularly rich in polyphenols (e.g., catechins, theaflavins, thearubigins, gallic acid, and flavonols), which are thought to contribute to the health benefits of tea. High intake of tea polyphenols has been described to prevent and/or attenuate a variety of chronic pathological conditions like cardiovascular diseases, neurodegenerative diseases, diabetes, and cancer. This review focuses on established antioxidant and anti-inflammatory properties of tea polyphenols and underlying mechanisms of their involvement in inflammatory bowel diseases (IBD). Tea polyphenols act as efficient antioxidants by inducing an endogenous antioxidant defense system and maintaining intracellular redox homeostasis. Tea polyphenols also regulate signaling pathways such as nuclear factor-κB, activator protein 1, signal transducer and activator of transcriptions, and nuclear factor E2-related factor 2, which are associated with IBD development. Accumulating pieces of evidence have indicated that tea polyphenols enhance epithelial barrier function and improve gut microbial dysbiosis, contributing to the management of inflammatory colitis. Therefore, this study suggests that supplementation of tea polyphenols could prevent inflammatory conditions and improve the outcome of patients with IBD.

Keywords: Gut microbiota, Antioxidant, Anti-inflammation, Tea polyphenols, Epithelial barrier function, Inflammatory bowel diseases

References(74)

[1]

H. Shapiro, P. Singer, Z. Halpern, et al., Polyphenols in the treatment of inflammatory bowel disease and acute pancreatitis, Gut 56 (2007) 426-435. http://doi.org/10.1136/gut.2006.094599

[2]

C. Manach, A. Scalbert, C. Morand, et al., Polyphenols: food sources and bioavailability, Am. J. Clin. Nutr. 79 (2004) 727-747. https://doi.org/10.1093/ajcn/79.5.727

[3]

H. Zhang, R. Tsao, Dietary polyphenols, oxidative stress and antioxidant and anti-inflammatory effects, Curr. Opin. Food Sci. 8 (2016) 33-42. https://doi.org/10.1016/j.cofs.2016.02.002

[4]

R. Tsao, Chemistry and biochemistry of dietary polyphenols, Nutrients 2 (2010) 1231-1246. https://doi.org/10.3390/nu2121231

[5]

S.P.J. Namal Senanayake, Green tea extract: chemistry, antioxidant properties and food applications – a review, J. Funct. Foods 5 (2013) 1529-1541. https://doi.org/10.1016/j.jff.2013.08.011

[6]

J.D. Lambert, R.J. Elias, The antioxidant and pro-oxidant activities of green tea polyphenols: a role in cancer prevention, Arch. Biochem. Biophys. 501 (2010) 65-72. https://doi.org/10.1016/j.abb.2010.06.013

[7]

L. Zhang, C.T. Ho, J. Zhou, et al., Chemistry and biological activities of processed Camellia sinensis teas: a comprehensive review, Compr. Rev. Food Sci. Food Saf. 18 (2019) 1474-1495. https://doi.org/10.1111/1541-4337.12479

[8]

Z. Yan, Y. Zhong, Y. Duan, et al., Antioxidant mechanism of tea polyphenols and its impact on health benefits, Anim. Nutr. 6 (2020) 115-123. https://doi.org/10.1016/j.aninu.2020.01.001

[9]

N. Khan, H. Mukhtar, Tea polyphenols for health promotion, Life Sci. 81 (2007) 519-533. https://doi.org/10.1016/j.lfs.2007.06.011

[10]

X.R. Yang, C.X. Ye, J.K. Xu, et al., Simultaneous analysis of purine alkaloids and catechins in Camellia sinensis, Camellia ptilophylla and Camellia assamica var. kucha by HPLC, Food Chem. 100 (2007) 1132-1136. https://doi.org/10.1016/j.foodchem.2005.11.021

[11]

C. Cabrera, R. Artacho, R. Giménez, Beneficial effects of green tea—a review, J. Am. Coll. Nutr. 25 (2006) 79-99. https://doi.org/10.1080/07315724.2006.10719518

[12]

N.T. Zaveri, Green tea and its polyphenolic catechins: medicinal uses in cancer and noncancer applications, Life Sci. 78 (2006) 2073-2080. https://doi.org/10.1016/j.lfs.2005.12.006

[13]

D.S. Wheeler, W.J. Wheeler, The medicinal chemistry of tea, Drug Dev. Res. 61 (2004) 45-65. https://doi.org/10.1002/ddr.10341

[14]

Y. Yilmaz, Novel uses of catechins in foods, Trends Food Sci. Technol. 17 (2006) 64-71. https://doi.org/10.1016/j.tifs.2005.10.005

[15]

M. Obanda, P.O. Owuor, R. Mang'oka, Changes in the chemical and sensory quality parameters of black tea due to variations of fermentation time and temperature, Food Chem. 75 (2001) 395-404. https://doi.org/10.1016/S0308-8146(01)00223-0

[16]

M. Weerawatanakorn, W.L. Hung, M.H. Pan, et al., Chemistry and health beneficial effects of oolong tea and theasinensins, Food Sci. Human Wellness 4 (2015) 133-146. https://doi.org/10.1016/j.fshw.2015.10.002

[17]

H.N. Graham, Green tea composition, consumption, and polyphenol chemistry, Prev. Med. 21 (1992) 334-350. https://doi.org/10.1016/0091-7435(92)90041-F

[18]

Y. Zuo, H. Chen, Y. Deng, Simultaneous determination of catechins, caffeine and gallic acids in green, oolong, black and pu-erh teas using HPLC with a photodiode array detector, Talanta 57 (2002) 307-316. https://doi.org/10.1016/S0039-9140(02)00030-9

[19]

H. Wang, K. Helliwell, Determination of flavonols in green and black tea leaves and green tea infusions by high-performance liquid chromatography, Food Res. Int. 34 (2001) 223-227. https://doi.org/10.1016/S0963-9969(00)00156-3

[20]

C.T. Scoparo, L.M. de Souza, N. Dartora, et al., Analysis of Camellia sinensis green and black teas via ultra high performance liquid chromatography assisted by liquid–liquid partition and two-dimensional liquid chromatography (size exclusion × reversed phase), J. Chromatogr. A, 1222 (2012) 29-37. https://doi.org/10.1016/j.chroma.2011.11.038

[21]

D. Furman, J. Campisi, E. Verdin, et al., Chronic inflammation in the etiology of disease across the life span, Nat. Med. 25 (2019) 1822-1832. https://doi.org/10.1038/s41591-019-0675-0

[22]

Y. Kabe, K. Ando, S. Hirao, et al., Redox regulation of NF-κB activation: distinct redox regulation between the cytoplasm and the nucleus, Antioxid. Redox Signal. 7 (2005) 395-403. https://doi.org/10.1089/ars.2005.7.395

[23]

S. Nakajima, M. Kitamura, Bidirectional regulation of NF-κB by reactive oxygen species: a role of unfolded protein response, Free Radic. Biol. Med. 65 (2013) 162-174. https://doi.org/10.1016/j.freeradbiomed.2013.06.020

[24]

A. Scalbert, C. Manach, C. Morand, et al., Dietary polyphenols and the prevention of diseases, Crit. Rev. Food Sci. Nutr. 45 (2005) 287-306. https://doi.org/10.1080/1040869059096

[25]

J.K. Nicholson, E. Holmes, J. Kinross, et al., Host-gut microbiota metabolic interactions, Science 336 (2012) 1262-1267. https://doi.org/10.1126/science.1223813

[26]

R. Singh, N. Akhtar, T.M. Haqqi, Green tea polyphenol epigallocatechi3-gallate: inflammation and arthritis, Life Sci. 86 (2010) 907-918. https://doi.org/10.1016/j.lfs.2010.04.013

[27]

S.U. Rahman, Y. Li, Y. Huang, L. et al., Treatment of inflammatory bowel disease via green tea polyphenols: possible application and protective approaches, Inflammopharmacology 26 (2018) 319-330. https://doi.org/10.1007/s10787-018-0462-4

[28]

A. Salaritabar, B. Darvishi, F. Hadjiakhoondi, et al., Therapeutic potential of flavonoids in inflammatory bowel disease: a comprehensive review, World J. Gastroenterol. 23 (2017) 5097-5114. https://doi.org/10.3748/wjg.v23.i28.5097

[29]

M.C. Mentella, F. Scaldaferri, M. Pizzoferrato, et al., Nutrition, IBD and gut microbiota: a review, Nutrients 12 (2020) 944. https://doi.org/10.3390/nu12040944

[30]

H. Li, L.M. Christman, R. Li, et al., Synergic interactions between polyphenols and gut microbiota in mitigating inflammatory bowel diseases, Food Funct. 11 (2020) 4878-4891. https://doi.org/10.1039/D0FO00713G

[31]

S.M. Barbalho, H. Bosso, L.M. Salzedas-Pescinini, et al., Green tea: a possibility in the therapeutic approach of inflammatory bowel diseases?: green tea and inflammatory bowel diseases, Complement. Ther. Med. 43 (2019) 148-153. https://doi.org/10.1016/j.ctim.2019.01.015

[32]

M. Mittal, M.R. Siddiqui, K. Tran, et al., Reactive oxygen species in inflammation and tissue injury, Antioxid. Redox Signal. 20 (2014) 1126-1167. https://doi.org/10.1089/ars.2012.5149

[33]

M. Valko, D. Leibfritz, J. Moncol, et al., Free radicals and antioxidants in normal physiological functions and human disease, Int. J. Biochem. Cell Biol. 39 (2007) 44-84. https://doi.org/10.1016/j.biocel.2006.07.001

[34]

Y. Zhen, H. Zhang, NLRP3 inflammasome and inflammatory bowel disease, Front. Immunol. 10 (2019) 276. https://doi.org/10.3389/fimmu.2019.00276

[35]

A. Abderrazak, T. Syrovets, D. Couchie, et al., NLRP3 inflammasome: from a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases, Redox Biol. 4 (2015) 296-307. https://doi.org/10.1016/j.redox.2015.01.008

[36]

S. Salim, J.D. Söderholm, Importance of disrupted intestinal barrier in inflammatory bowel diseases, Inflamm. Bowel Dis. 17 (2011) 362-381. https://doi.org/10.1002/ibd.21403

[37]

A. Kumar Singh, C. Cabral, R. Kumar, et al., Beneficial effects of dietary polyphenols on gut microbiota and strategies to improve delivery efficiency, Nutrients 11 (2019) 2216. https://doi.org/10.3390/nu11092216

[38]

R.S. Blumberg, Inflammation in the intestinal tract: pathogenesis and treatment, Dig. Dis. 27 (2009) 455-464. https://doi.org/10.1159/000235851

[39]

M.C. Choy, K. Visvanathan, P. De Cruz, An overview of the innate and adaptive immune system in inflammatory bowel disease, Inflamm. Bowel Dis. 23 (2017) 2-13. https://doi.org/10.1097/MIB.0000000000000955

[40]

D.A. Martin, B.W. Bolling, A review of the efficacy of dietary polyphenols in experimental models of inflammatory bowel diseases, Food Funct. 6 (2015) 1773-1786. https://doi.org/10.1039/C5FO00202H

[41]

H. Inoue, M. Maeda-Yamamoto, A. Nesumi, et al., Low and medium but not high doses of green tea polyphenols ameliorated dextran sodium sulfate-induced hepatotoxicity and nephrotoxicity, Biosci. Biotechnol. Biochem. 77 (2013) 1223-1228. https://doi.org/10.1271/bbb.121003

[42]

M. Kim, A. Murakami, S. Miyamoto, et al., The modifying effects of green tea polyphenols on acute colitis and inflammation-associated colon carcinogenesis in male ICR mice, BioFactors 36 (2010) 43-51. https://doi.org/10.1002/biof.69

[43]

H. Oz, T. Chen, W. de Villiers, Green tea polyphenols and sulfasalazine have parallel anti-inflammatory properties in colitis models, Front. Immunol. 4 (2013) 132. https://doi.org/10.3389/fimmu.2013.00132

[44]

P.A. Abboud, P.W. Hake, T.J. Burroughs, et al., Therapeutic effect of epigallocatechin-3-gallate in a mouse model of colitis, Eur. J. Pharmacol. 579 (2008) 411-417. https://doi.org/10.1016/j.ejphar.2007.10.053

[45]

G.W. Varilek, F. Yang, E.Y. Lee, et al., Green tea polyphenol extract attenuates inflammation in interleukin-2–deficient mice, a model of autoimmunity, J. Nutr. 131 (2001) 2034-2039. https://doi.org/10.1093/jn/131.7.2034

[46]

M.P.G. Barnett, J.M. Cooney, Y.E.M. Dommels, et al., Modulation of colonic inflammation in Mdr1a−/− mice by green tea polyphenols and their effects on the colon transcriptome and proteome, J. Nutr. Biochem. 24 (2013) 1678-1690. https://doi.org/10.1016/j.jnutbio.2013.02.007

[47]

Y. Liu, X. Wang, Q. Chen, et al., Camellia sinensis and Litsea coreana ameliorate intestinal inflammation and modulate gut microbiota in dextran sulfate sodium-induced colitis mice, Mol. Nutr. Food Res. 64 (2020) 1900943. https://doi.org/10.1002/mnfr.201900943

[48]

E. Mazzon, C. Muià, R.D. Paola, et al., Green tea polyphenol extract attenuates colon injury induced by experimental colitis, Free Radic. Res. 39 (2005) 1017-1025. https://doi.org/10.1080/10715760500197177

[49]

Y.A. Song, Y.L. Park, K.Y. Kim, et al., Black tea extract prevents lipopolysaccharide-induced NF-κB signaling and attenuates dextran sulfate sodium-induced experimental colitis, BMC Complement. Altern. Med. 11 (2011) 91. https://doi.org/10.1186/1472-6882-11-91

[50]

Y. Liu, L. Luo, Y. Luo, et al., Prebiotic properties of green and dark tea contribute to protective effects in chemical-induced colitis in mice: a fecal microbiota transplantation study, J. Agric. Food Chem. 68 (2020) 6368-6380. https://doi.org/10.1021/acs.jafc.0c02336

[51]

Z. Xu, C. Wei, R.U. Zhang, et al., Epigallocatechin-3-gallate-induced inhibition of interleukin-6 release and adjustment of the regulatory T/T helper 17 cell balance in the treatment of colitis in mice, Exp. Ther. Med., 10 (2015) 2231-2238. https://doi.org/10.3892/etm.2015.2824

[52]

G.W. Dryden, A. Lam, K. Beatty, et al., A pilot study to evaluate the safety and efficacy of an oral dose of (−)-epigallocatechin-3-gallate–rich polyphenone in patients with mild to moderate ulcerative colitis, Inflamm. Bowel Dis. 19 (2013) 1904-1912

[53]

Z.H. Ran, C. Chen, S.D. Xiao, Epigallocatechin-3-gallate ameliorates rats colitis induced by acetic acid, Biomed. Pharmacother. 62 (2008) 189-196. https://doi.org/10.1016/j.biopha.2008.02.002

[54]

Y.S. Chiou, N.J.L. Ma, S. Sang, et al., Peracetylated (−)-epigallocatechin-3-gallate (acegcg) potently suppresses dextran sulfate sodium-induced colitis and colon tumorigenesis in mice, J. Agric. Food Chem. 60 (2012) 3441-3451. https://doi.org/10.1021/jf300441p

[55]

A.K. Pandurangan, N. Mohebali, M.E. Norhaizan, et al., Gallic acid attenuates dextran sulfate sodium-induced experimental colitis in BALB/c mice, Drug Des. Devel. Ther. 9 (2015) 3923-3934. https://doi.org/10.2147/dddt.s86345

[56]

J. Ni, T.C.D. Shen, E.Z. Chen, et al., A role for bacterial urease in gut dysbiosis and Crohn's disease, Sci. Transl. Med. 9 (2017) eaah6888. https://doi.org/10.1126/scitranslmed.aah6888

[57]

R.B. Sartor, G.D. Wu, Roles for intestinal bacteria, viruses, and fungi in pathogenesis of inflammatory bowel diseases and therapeutic approaches, Gastroenterology 152 (2017) 327-339. https://doi.org/10.1053/j.gastro.2016.10.012

[58]

F.Y. Fan, L.X. Sang, M. Jiang, Catechins and their therapeutic benefits to inflammatory bowel disease, Molecules 22 (2017) 484. https://doi.org/10.3390/molecules22030484

[59]

J.C. Clemente, J. Manasson, J.U. Scher, The role of the gut microbiome in systemic inflammatory disease, BMJ 360 (2018) 5145. https://doi.org/10.1136/bmj.j5145

[60]

D.J. Hampson, K. Lugsomya, T. La, et al., Antimicrobial resistance in Brachyspira – an increasing problem for disease control, Vet. Microbiol. 229 (2019) 59-71. https://doi.org/10.1016/j.vetmic.2018.12.019

[61]

D. Berry, C. Schwab, G. Milinovich, et al., Phylotype-level 16S rRNA analysis reveals new bacterial indicators of health state in acute murine colitis, ISME J. 6 (2012) 2091-2106. https://doi.org/10.1038/ismej.2012.39

[62]

A. Loy, C. Pfann, M. Steinberger, et al., Lifestyle and horizontal gene transfer-mediated evolution of Mucispirillum schaedleri, a core member of the murine gut microbiota, mSystems 2 (2017) e00171-16. https://doi.org/10.1128/mSystems.00171-16

[63]

R. Caruso, T. Mathes, E.C. Martens, et al., A specific gene-microbe interaction drives the development of Crohn's disease–like colitis in mice, Sci. Immunol. 4 (2019) eaaw4341. https://doi.org/10.1126/sciimmunol.aaw4341

[64]

I. O'Neill, Z. Schofield, L.J. Hall, Exploring the role of the microbiota member Bifidobacterium in modulating immune-linked diseases, Emerging Top. Life Sci. 1 (2017) 333-349. https://doi.org/10.1042/ETLS20170058

[65]

T.V. Hung, T. Suzuki, Short-chain fatty acids suppress inflammatory reactions in Caco-2 cells and mouse colons, J. Agric. Food Chem. 66 (2018) 108-117. https://doi.org/10.1021/acs.jafc.7b04233

[66]

J. Landy, E. Ronde, N. English, et al., Tight junctions in inflammatory bowel diseases and inflammatory bowel disease associated colorectal cancer, World J. Gastroenterol. 22 (2016) 3117-3126. https://doi.org/10.3748/wjg.v22.i11.3117

[67]

S.M. Vindigni, T.L. Zisman, D.L. Suskind, et al., The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions, Therap. Adv. Gastroenterol. 9 (2016) 606-625. https://doi.org/10.1177/1756283X16644242

[68]

R. Singh, S. Chandrashekharappa, S.R. Bodduluri, et al., Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway, Nat. Commun. 10 (2019) 89. https://doi.org/10.1038/s41467-018-07859-7

[69]

L. Zhang, S. Gui, J. Wang, et al., Oral administration of green tea polyphenols (TP) improves ileal injury and intestinal flora disorder in mice with Salmonella typhimurium infection via resisting inflammation, enhancing antioxidant action and preserving tight junction, J. Funct. Foods 64 (2020) 103654. https://doi.org/10.1016/j.jff.2019.103654

[70]

T.C. Contreras, E. Ricciardi, E. Cremonini, et al., (−)-Epicatechin in the prevention of tumor necrosis alpha-induced loss of Caco-2 cell barrier integrity, Arch. Biochem. Biophys. 573 (2015) 84-91. https://doi.org/10.1016/j.abb.2015.01.024

[71]

C. Carrasco-Pozo, P. Morales, M. Gotteland, Polyphenols protect the epithelial barrier function of Caco-2 cells exposed to indomethacin through the modulation of occludin and zonula occludens-1 expression, J. Agric. Food Chem. 61 (2013) 5291-5297. https://doi.org/10.1021/jf400150p

[72]

J.L. Watson, S. Ansari, H. Cameron, et al., Green tea polyphenol (−)-epigallocatechin gallate blocks epithelial barrier dysfunction provoked by IFN-γ but not by IL-4, Am. J. Physiol. Gastrointest. Liver Physiol. 287 (2004) 954-961. https://doi.org/10.1152/ajpgi.00302.2003

[73]

J.L. Watson, M. Vicario, A. Wang, et al., Immune cell activation and subsequent epithelial dysfunction by Staphylococcus enterotoxin B is attenuated by the green tea polyphenol (−)-epigallocatechin gallate, Cell. Immunol. 237 (2005) 7-16. https://doi.org/10.1016/j.cellimm.2005.08.030

[74]

H.Y. Park, Y. Kunitake, N. Hirasaki, et al., Theaflavins enhance intestinal barrier of Caco-2 cell monolayers through the expression of AMP-activated protein kinase-mediated occludin, claudin-1, and ZO-1, Biosci. Biotechnol. Biochem. 79 (2015) 130-137. https://doi.org/10.1080/09168451.2014.951027

Publication history
Copyright
Rights and permissions

Publication history

Received: 27 December 2020
Revised: 01 February 2021
Accepted: 01 February 2021
Published: 04 February 2022
Issue date: May 2022

Copyright

© 2022 Beijing Academy of Food Sciences.

Rights and permissions

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Return